Actively Recruiting
Phase 1 Study of Oral Trichuris trichiura Egg Inoculum in Healthy Adults Aged 18 to 45 to Assess Safety and Infection Dose
Led by George Washington University · Updated on 2026-06-04
18
Participants Needed
2
Research Sites
27 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are developing a Controlled Human Infection Model to test whether experimental infection with the intestinal worm Trichuris trichiura can be safely and reliably established in healthy adults who have never had this infection. This Phase 1 feasibility study aims to find the best dose of Trichuris trichiura eggs that causes consistent infection without causing significant side effects. The study involves three groups of healthy adult volunteers who will receive a single oral dose of Trichuris trichiura Egg Inoculum containing either 150, 300, or optionally 450 embryonated eggs. The groups will be enrolled one after the other with at least 16 weeks between doses to monitor safety. The study lasts about 10 months for each participant, allowing thorough follow-up. Participants will be monitored closely for any adverse events, including laboratory tests for blood counts and organ function, over several months after dosing. Researchers will also check stool samples for evidence of infection using egg counts and DNA tests. The study will assess safety, tolerability, and infection consistency over about 7 months post-inoculation, with comprehensive monitoring through roughly 10 months total.
CONDITIONS
Brief Title
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
Research Team
D
David Diemert, MD
L
Laura Vasquez, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here